News

For the second quarter of fiscal 2009, the company reported increased net revenue included product revenue of $8,061,000 for the second quarter of fiscal 2009, an 8.2% increase,

The decision was made based on the results of the Phase III study of maribavir in stem cell transplant patients, and the recommendation from the independent data monitoring

Mr Gallahue has successfully participated in a variety of financial transactions, including initial public offerings, mergers, joint ventures, private placements and follow-on offerings at a number of healthcare

Cardinal Health said that the new company will be named CareFusion, reflecting a diverse blend of medical technologies the company will offer to improve the safety and quality

Denver Health is receiving funding for the study as a team science award from the Colorado Clinical and Translational Sciences Institute. Accelr8 has provided analytical instrumentation to Denver

Monet1 is a Phase III study evaluating motesanib in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-squamous non-small cell lung cancer (NSCLC). Motesanib is

The first clinical case was successfully performed by Karl-Heinz Kuck, director of the cardiologic center at the Asklepios Klinik in Hamburg, Germany, said Biotronik. During this case a

In this capacity Ms Baird will provide leadership and strategic direction in the areas of regulatory and quality affairs and in clinical operations. Most recently, Ms Baird was

“In his eight years at Novo Nordisk, Andy has developed an impressive track record for building high performing field sales teams,” said Jerzy Gruhn, president of Novo Nordisk